Ta-chen Huang
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Cabozantinib and atezolizumab for recurrent or metastatic esophageal squamous cell carcinoma after platinum-based chemotherapy failure: a single-arm phase II study and biomarker analysis.
Journal: Cancer immunology, immunotherapy : CII
Published: January 26, 2026
Neoadjuvant immunochemoradiotherapy with nivolumab, paclitaxel, and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.
Journal: British journal of cancer
Published: August 28, 2025
Clinical Outcome of Conversion Surgery for Stage IV Esophageal Cancer Following Chemoradiation.
Journal: Biomedicines
Published: February 04, 2025
Tertiary lymphoid structures predict outcomes of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
Journal: BMC cancer
Published: November 28, 2024
Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study.
Journal: Cancer immunology, immunotherapy : CII
Published: June 12, 2024
Prognostication and optimal criteria of circumferential margin involvement for esophageal cancer after chemoradiation and esophagectomy.
Journal: Frontiers in oncology
Published: November 30, 2022
Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: April 06, 2022
B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma.
Journal: Frontiers in oncology
Published: February 19, 2022
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy.
Journal: Journal of cancer research and clinical oncology
Published: June 20, 2021
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites.
Journal: Oncology
Published: May 18, 2021
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
Journal: Anticancer research
Published: August 09, 2019
Last Updated: 09/26/2026